Staphylococcus aureus in agriculture: lessons in evolution from a multispecies pathogen

S Park, J Ronholm - Clinical microbiology reviews, 2021 - Am Soc Microbiol
Staphylococcus aureus is a formidable bacterial pathogen that is responsible for infections
in humans and various species of wild, companion, and agricultural animals. The ability of S …

Clinical pharmacokinetics and pharmacodynamics of oxazolidinones

C Roger, JA Roberts, L Muller - Clinical pharmacokinetics, 2018 - Springer
Oxazolidinones are a class of synthetic antimicrobial agents with potent activity against a
wide range of multidrug-resistant Gram-positive pathogens including methicillin-resistant …

Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options

SM Purrello, J Garau, E Giamarellos, T Mazzei… - Journal of Global …, 2016 - Elsevier
This review is the result of discussions that took place at the 5th MRSA Working Group
Consensus Meeting and explores the possible treatment options available for different types …

Is It Time to Replace Vancomycin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections?

SJ Van Hal, VG Fowler Jr - Clinical infectious diseases, 2013 - academic.oup.com
For more than 4 decades, vancomycin has been the antibiotic of choice for methicillin-
resistant Staphylococcus aureus (MRSA) infections. Recently, infections due to isolates with …

Epidermin and gallidermin: Staphylococcal lantibiotics

F Götz, S Perconti, P Popella, R Werner… - International Journal of …, 2014 - Elsevier
The Staphylococcus epidermidis derived epidermin was the first lantibiotic that has been
shown to be ribosomally synthesized and posttranslationally modified. Together with …

The empirical combination of vancomycin and a β-lactam for staphylococcal bacteremia

KW McConeghy, SC Bleasdale… - Clinical infectious …, 2013 - academic.oup.com
The high prevalence of methicillin resistance among Staphylococcus aureus bacteremias
leads to common use of vancomycin as empirical therapy. However, investigators have …

Clinical update on linezolid in the treatment of Gram-positive bacterial infections

S Ager, K Gould - Infection and drug resistance, 2012 - Taylor & Francis
Gram-positive pathogens are a significant cause of morbidity and mortality in both
community and health care settings. Glycopeptides have traditionally been the antibiotics of …

Staphylococcins: an update on antimicrobial peptides produced by staphylococci and their diverse potential applications

MC de Freire Bastos, F Miceli de Farias… - Applied Microbiology …, 2020 - Springer
Staphylococcins are antimicrobial peptides or proteins produced by staphylococci. They can
be separated into different classes, depending on their amino acid composition, structural …

Economic Features of Antibiotic Resistance: The Case of Methicillin-Resistant Staphylococcus aureus

F Antonanzas, C Lozano, C Torres - Pharmacoeconomics, 2015 - Springer
This paper analyses and updates the economic information regarding methicillin-resistant
Staphylococcus aureus (MRSA), including information that has been previously reviewed by …

An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy

RR Watkins, TL Lemonovich, TM File Jr - Core evidence, 2012 - Taylor & Francis
Methicillin-resistant Staphylococcus aureus (MRSA), including community-associated and
hospital-associated strains, is a major cause of human morbidity and mortality. Treatment …